Encompass Health Net Income 2012-2026 | EHC
Encompass Health annual/quarterly net income history and growth rate from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Encompass Health net income for the quarter ending June 30, 2026 was $0.154B, a 8.33% increase year-over-year.
- Encompass Health net income for the twelve months ending June 30, 2026 was $621M, a 18.9% increase year-over-year.
- Encompass Health annual net income for 2025 was $0.566B, a 24.25% increase from 2024.
- Encompass Health annual net income for 2024 was $0.456B, a 29.46% increase from 2023.
- Encompass Health annual net income for 2023 was $0.352B, a 29.89% increase from 2022.
|
Encompass Health Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $566 |
| 2024 | $456 |
| 2023 | $352 |
| 2022 | $271 |
| 2021 | $412 |
| 2020 | $284 |
| 2019 | $359 |
| 2018 | $292 |
| 2017 | $271 |
| 2016 | $248 |
| 2015 | $182 |
| 2014 | $216 |
| 2013 | $231 |
| 2012 | $160 |
| 2011 | $183 |
|
Encompass Health Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2026-06-30 | $154 |
| 2026-03-31 | $195 |
| 2025-12-31 | $147 |
| 2025-09-30 | $127 |
| 2025-06-30 | $142 |
| 2025-03-31 | $152 |
| 2024-12-31 | $121 |
| 2024-09-30 | $108 |
| 2024-06-30 | $114 |
| 2024-03-31 | $113 |
| 2023-12-31 | $88 |
| 2023-09-30 | $85 |
| 2023-06-30 | $91 |
| 2023-03-31 | $88 |
| 2022-12-31 | $89 |
| 2022-09-30 | $45 |
| 2022-06-30 | $49 |
| 2022-03-31 | $88 |
| 2021-12-31 | $92 |
| 2021-09-30 | $100 |
| 2021-06-30 | $113 |
| 2021-03-31 | $107 |
| 2020-12-31 | $86 |
| 2020-09-30 | $78 |
| 2020-06-30 | $34 |
| 2020-03-31 | $87 |
| 2019-12-31 | $68 |
| 2019-09-30 | $97 |
| 2019-06-30 | $91 |
| 2019-03-31 | $102 |
| 2018-12-31 | $28 |
| 2018-09-30 | $89 |
| 2018-06-30 | $92 |
| 2018-03-31 | $84 |
| 2017-12-31 | $75 |
| 2017-09-30 | $66 |
| 2017-06-30 | $63 |
| 2017-03-31 | $67 |
| 2016-12-31 | $65 |
| 2016-09-30 | $62 |
| 2016-06-30 | $63 |
| 2016-03-31 | $58 |
| 2015-12-31 | $47 |
| 2015-09-30 | $51 |
| 2015-06-30 | $43 |
| 2015-03-31 | $41 |
| 2014-12-31 | $41 |
| 2014-09-30 | $49 |
| 2014-06-30 | $82 |
| 2014-03-31 | $45 |
| 2013-12-31 | $-27 |
| 2013-09-30 | $53 |
| 2013-06-30 | $159 |
| 2013-03-31 | $46 |
| 2012-12-31 | $42 |
| 2012-09-30 | $41 |
| 2012-06-30 | $40 |
| 2012-03-31 | $37 |
| 2011-12-31 | $44 |
| 2011-09-30 | $51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $12.224B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Elanco Animal Health (ELAN) | United States | $11.421B | 21.57 |
| Chemed (CHE) | United States | $6.665B | 23.76 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.112B | 21.61 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |